UK: Healthcare investment: more than just big pharma!
Historically, when investors thought of healthcare in the investment world, they would normally go straight to big pharma – the likes of Johnson & Johnson, Pfizer, Roche or GlaxoSmithKline come to mind.
However, the emergence of various megatrends in recent years has created opportunities beyond big pharma (e.g. medtech, biotech, healthcare equipment & services, insurance) that investors can benefit from, across a range of asset classes.
The two specific megatrends, out of the five key megatrends that we expect to shape the trajectory of the global economy, are demographics and technological advancement.
Read the full article at Barnett Waddingham.